Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?



Rating:

Share or cite this content

Citations should be made in the following way:
I. de Monestrol, A. Klint, P. Sparén, L. Hjelte (Stockholm, Sweden). CF disease progress regarding lung symptoms – a cohort study. Eur Respir J 2007; 30: Suppl. 51, 355

Member's Comments

No comment yet.

Related content which might interest you: A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 A prospective cohort study on the effects of pulmonary rehabilitation on non-COPD lung disease Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients Year: 2007 Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 The presence and impact of chronic kidney disease in COPD patients, data from the German COSYCONET cohort Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 Early symptoms in suspected lung cancer: a prospective cohort study Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001 A retrospective evaluation of lung function and exacerbations in COPD patients-RETRIEVE study. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU) Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018 A longitudinal study about lung function and symptoms in patients with pollution-related illness Source: Annual Congress 2012 - Indoor and outdoor air pollution Year: 2012 Cross-sectional study on therapeutic adherence and disease knowledge of patients affected by chronic obstructive pulmonary disease. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Longitudinal study of lung function in exacerbations of COPD patients during 10 years Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Frequency and characterization of sleep related disorders in interstitial lung disease patients: a prospective study Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Longitudinal, home-based study of lung function, saturation and disease-related symptoms in COPD Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease? Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019